Table 4.
Application of the proposed method to the analysis of methocarbamol and guaifenesin in their dosage forms
| Parameters | Methocarbamol | Guaifenesin | ||||
|---|---|---|---|---|---|---|
| Conc. taken (µg/mL) | %found | Comparison method [42] | Conc. Taken (µg/mL) | %found | Comparison method [43] | |
| Dosage forms | 20.0 | 100 | 100.6 | 5.0 | 100.2 | 99.5 |
| 30.0 | 100 | 100.1 | 10.0 | 100.9 | 100 | |
| 40.0 | 96.9 | 99.8 | 20.0 | 100.5 | 99.2 | |
| 50.0 | 97.6 | 99.2 | 30.0 | 100.3 | 100 | |
| 60.0 | 102.1 | 100.5 | 40.0 | 102.5 | 100 | |
| Mean ± SD | 98.97 ± 1.79 | 100.17 ± 0.4 | 100.53 ± 0.35 | 99.56 ± 0.4 | ||
| t test | 0.86 (2.776)* | 0.04 (2.776)* | ||||
| F test | 4.41 (6.388)* | 1.31 (6.388)* | ||||
∗Tabulated t and F values at p = 0.05[44]